Szczegóły publikacji
Opis bibliograficzny
Mass spectrometry imaging of biomaterials / Paulina KRET, Anna BODZOŃ-KUŁAKOWSKA, Anna DRABIK, Joanna NER-KLUZA, Piotr SUDER, Marek SMOLUCH // Materials [Dokument elektroniczny]. — Czasopismo elektroniczne ; ISSN 1996-1944. — 2023 — vol. 16 iss. 18 art. no. 6343, s. 1–29. — Wymagania systemowe: Adobe Reader. — Bibliogr. s. 25–29, Abstr. — Publikacja dostępna online od: 2023-09-21
Autorzy (6)
Słowa kluczowe
Dane bibliometryczne
| ID BaDAP | 148786 |
|---|---|
| Data dodania do BaDAP | 2023-09-22 |
| Tekst źródłowy | URL |
| DOI | 10.3390/ma16186343 |
| Rok publikacji | 2023 |
| Typ publikacji | artykuł w czasopiśmie |
| Otwarty dostęp |  |
| Creative Commons | |
| Czasopismo/seria | Materials |
Abstract
The science related to biomaterials and tissue engineering accounts for a growing part of our knowledge. Surface modifications of biomaterials, their performance in vitro, and the interaction between them and surrounding tissues are gaining more and more attention. It is because we are interested in finding sophisticated materials that help us to treat or mitigate different disorders. Therefore, efficient methods for surface analysis are needed. Several methods are routinely applied to characterize the physical and chemical properties of the biomaterial surface. Mass Spectrometry Imaging (MSI) techniques are able to measure the information about molecular composition simultaneously from biomaterial and adjacent tissue. That is why it can answer the questions connected with biomaterial characteristics and their biological influence. Moreover, this kind of analysis does not demand any antibodies or dyes that may influence the studied items. It means that we can correlate surface chemistry with a biological response without any modification that could distort the image. In our review, we presented examples of biomaterials analyzed by MSI techniques to indicate the utility of SIMS, MALDI, and DESI—three major ones in the field of biomaterials applications. Examples include biomaterials used to treat vascular system diseases, bone implants with the effects of implanted material on adjacent tissues, nanofibers and membranes monitored by mass spectrometry-related techniques, analyses of drug-eluting long-acting parenteral (LAPs) implants and microspheres where MSI serves as a quality control system.